BCM
FLGT icon

Bridgeway Capital Management’s Fulgent Genetics FLGT Stock Holding History

Bridgeway Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25,378
Closed -$429K – 1199
2025
Q1 		$429K Sell
25,378
-72,341
-74% -$1.23M 0.01% 771
2024
Q4 		$1.8M Sell
97,719
-20,391
-17% -$398K 0.04% 543
2024
Q3 		$2.57M Sell
118,110
-5,444
-4% -$122K 0.06% 463
2024
Q2 		$2.42M Sell
123,554
-38,321
-24% -$800K 0.06% 451
2024
Q1 		$3.51M Buy
161,875
+8,225
+5% +$204K 0.07% 398
2023
Q4 		$4.44M Sell
153,650
-40,976
-21% -$1.1M 0.1% 340
2023
Q3 		$5.2M Buy
194,626
+7,426
+4% +$254K 0.13% 266
2023
Q2 		$6.93M Buy
187,200
+16,975
+10% +$592K 0.17% 189
2023
Q1 		$5.31M Sell
170,225
-39,075
-19% -$1.26M 0.14% 235
2022
Q4 		$6.23M Buy
209,300
+25,000
+14% +$895K 0.16% 204
2022
Q3 		$7.03M Buy
184,300
+25,000
+16% +$1.25M 0.19% 167
2022
Q2 		$8.69M Buy
+159,300
New +$8.75M 0.2% 160
2020
Q1 		– Sell
-78,100
Closed -$1.01M – 1312
2019
Q4 		$1.01M Hold
78,100
– – 0.01% 736
2019
Q3 		$811K Hold
78,100
– – 0.01% 785
2019
Q2 		$522K Hold
78,100
– – 0.01% 965
2019
Q1 		$465K Hold
78,100
– – 0.01% 1043
2018
Q4 		$248K Hold
78,100
– – ﹤0.01% 1179
2018
Q3 		$307K Hold
78,100
– – ﹤0.01% 1251
2018
Q2 		$323K Hold
78,100
– – ﹤0.01% 1236
2018
Q1 		$311K Hold
78,100
– – ﹤0.01% 1195
2017
Q4 		$342K Hold
78,100
– – ﹤0.01% 1185
2017
Q3 		$369K Buy
+78,100
New +$449K ﹤0.01% 1166

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bridgeway Capital Management's FLGT Position: Q2 2025 in Review

Bridgeway Capital Management sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 25,378 shares — an estimated $429K sold.

Bridgeway Capital Management first reported a position in FLGT in Q3 2017 and held it in 22 quarters. The position peaked at $8.69M in Q2 2022. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

  • Bridgeway Capital Management reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 25,378 Fulgent Genetics shares in Q2 2025, an estimated $429K.
  • Bridgeway Capital Management first reported a position in Fulgent Genetics in Q3 2017 and held it in 22 quarters.
  • Bridgeway Capital Management's Fulgent Genetics position peaked at $8.69M in Q2 2022.
  • 167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.